Abstract: New compositions for and methods of treating ocular hypertension provide for effective treatment of ocular hypertension often using reduced concentrations of active components. Such compositions include a timolol component and a hypotensive lipid component. The present compositions and methods are relatively straightforward, can be easily produced, for example, using conventional manufacturing techniques, and can be easily and conveniently practiced, for example, using application or administration techniques or methodologies which are substantially similar to those employed with prior compositions used to treat ocular hypertension.
Type:
Application
Filed:
May 22, 2002
Publication date:
April 10, 2003
Applicant:
Bardeen Sciences Co., LLC
Inventors:
June Chen, David F. Woodward, Alexander B. Kharlamb